Clin2
NCT07058974Possibly a fitActive, not recruiting

Exercise and medication study for inflammation in older smokers

SmokersFormer Smokers

Treatments studied

Part of Immune system & allergy, Lungs & breathing clinical trials.

This trial tests whether a medication called rapamycin, combined with exercise, can lower inflammation in the body. It may help people aged 65-80 who smoke or used to smoke and have a body mass index between 25 and 32.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
60 years to 85 years
Study type
Interventional

Who can take part

  • You are between 65 and 80 years old
  • You are a current or former smoker
  • Your body mass index (BMI) is between 25 and 32
  • You have not had cancer treatment in the last 2 years
  • You do not have an autoimmune disease that requires special medication
  • You do not have advanced kidney disease, severe heart failure, or other serious health problems listed

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06658093Recruiting· Early Phase 1
RESTOR: Study of mTOR inhibitors in older adults

This trial tests two FDA-approved drugs, rapamycin and everolimus, to see if they can improve immune function in healthy older adults. You may join if you are generally healthy, live independently, and are between 65 and 90 years old.

San Antonio, Texas
NCT05414292Recruiting
Testing rapamycin effect on exercise muscle function in older adults

This study looks at how rapamycin (a medication that affects a growth signal in the body) changes muscle responses when older adults do resistance exercise. It may help researchers understand whether this treatment could improve or alter muscle function with aging.

Derby
NCT05392582Recruiting
Study tiny gene signals to calm inflammation with aging

This trial studies tiny gene-like signals (microRNAs) to understand and reduce long-term inflammation as people get older. It may help researchers learn how aging affects inflammation and could guide future treatments.

Salt Lake City, Utah
NCT07030920Recruiting· Phase 2
Reducing inflammation in people living with HIV

This trial tests if a drug can lower inflammation in people with HIV who are on effective treatment. It may help reduce the risk of heart disease and other problems related to chronic inflammation.

Montreal, Quebec
NCT06980896Not yet recruiting
Physical activity, inflammation and aging study

This study looks at how physical activity affects inflammation and cell stress in older adults. If you are 70 to 90, relatively healthy, and not frail, you may be able to join by having a blood test as part of your regular checkup.

Nantes, Nantes
NCT06507189Recruiting
How exercise affects older adults: a study

This study looks at how different older adults respond to exercise. It will help researchers understand why some people benefit more than others. You will be asked to do supervised exercise sessions and tests over about 6 months.

Pensacola, Florida

Hear when a new Smokers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.